Kendall Law Group Investigates Chattem Inc. on Behalf of Shareholders

Kendall Law Group, founded by a former federal judge, is investigating the proposed acquisition of Chattem Inc. (NASDAQ: CHTT) by Sanofi-Aventis in a $1.9 billion transaction. The investigation concerns whether the consideration to be paid to shareholders in this transaction is unfair and substantially below the fair or inherent value of the company. Also, the investigation will focus on whether the Board of Directors of Chattem may have breached their fiduciary duties by not adequately shopping the Company before entering into the transaction.

On December 21, 2009, Sanofi announced that it has reached an agreement to purchase Chattem Inc. According to the agreement, shareholders will receive $93.50 in cash per CHTT share owned. This represents approximately 34% premium over the closing price of $69.98 of Chattem on the last trading day before the announcement.

If you are a current holder of CHTT and would like additional information concerning this proposed transaction, including your rights, contact Hamilton Lindley at 877-744-3728 or by email at [e-mail]. Kendall Law Group has substantial experience representing investors in mergers and acquisitions nationwide. Lawyers at the firm include a former United States Attorney, federal judicial law clerk, a former state and federal judge, in addition to experienced securities lawyers.